| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/01/2011 | CA2469154C Cytotoxic protein and utilization thereof |
| 03/01/2011 | CA2349098C Assay for aldehyde content |
| 03/01/2011 | CA2348488C Novel agents and methods for treatment and diagnosis of ocular disorders |
| 03/01/2011 | CA2342203C Method for removal of hiv and other viruses from blood |
| 03/01/2011 | CA2323525C Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 03/01/2011 | CA2217820C Milk and milk products for preventing or treating heart disease |
| 02/28/2011 | CA2713804A1 Multi-analyte test strip with shared counter/reference electrode and inline electrode configuration |
| 02/28/2011 | CA2713793A1 Molecular weight markers for membrane proteins |
| 02/28/2011 | CA2712899A1 Gas detector with visual compliance verification |
| 02/28/2011 | CA2676946A1 Adam12 inhibitors and their use against inflammation-induced fibrosis |
| 02/24/2011 | WO2011022732A2 Apparatus and method for measuring biochemical parameters |
| 02/24/2011 | WO2011022709A1 In vitro screening assays |
| 02/24/2011 | WO2011022677A1 Optical nanosensors comprising photoluminescent nanostructures |
| 02/24/2011 | WO2011022628A1 Methods and compositions for diagnosis of acute myocardial infarction (ami) |
| 02/24/2011 | WO2011022590A2 Heavy metal remediation system |
| 02/24/2011 | WO2011022589A2 Detection of enterovirus |
| 02/24/2011 | WO2011022552A2 Marker Detection for Characterizing the Risk of Cardiovascular Disease or Complications Thereof |
| 02/24/2011 | WO2011022526A1 Identification and quantification of biomarkers for evaluating the risk of preterm birth |
| 02/24/2011 | WO2011022451A1 Human skin explant culture system and use therefor |
| 02/24/2011 | WO2011022438A2 Cleavage sensitive antibodies and methods of use thereof |
| 02/24/2011 | WO2011022316A1 Mirnas dysregulated in triple-negative breast cancer |
| 02/24/2011 | WO2011022278A1 Fluid specimen collection device |
| 02/24/2011 | WO2011022254A2 Capacitive oil quality monitoring sensor with fluorinated barrier coating |
| 02/24/2011 | WO2011022121A2 Analyte sensor fabrication |
| 02/24/2011 | WO2011022093A2 Methods and devices for detecting the presence of an analyte in a sample |
| 02/24/2011 | WO2011022074A1 Riboflavin based aerosol and use as placebo in trials |
| 02/24/2011 | WO2011022064A2 Analytic device with 2d scanning mirror reader |
| 02/24/2011 | WO2011022054A2 Diagnosing and managing venous thromboembolism and intracardiac thrombi using a provoked d-dimer test |
| 02/24/2011 | WO2011021896A2 Diagnostic system of using diagnostic kit |
| 02/24/2011 | WO2011021779A2 Method for evaluating water quality and toxicity using the growth rate of germ tubes of spores of algae belonging to the order laminariales |
| 02/24/2011 | WO2011021778A2 Method for evaluating water quality and toxicity using the germination rate of spores of algae belonging to the order laminariales, and kit for evaluating water quality and toxicity |
| 02/24/2011 | WO2011021657A1 Method for quantification of l-lysine in biological sample |
| 02/24/2011 | WO2011021581A1 Selective marker for target biopolymer |
| 02/24/2011 | WO2011021386A1 Cstf2 for target genes of lung cancer therapy and diagnosis |
| 02/24/2011 | WO2011021308A1 NUCLEIC ACID MOLECULE HAVING AFFINITY WITH IgG ANTIBODY DERIVED FROM RODENT, BINDING AGENT, DETECTION REAGENT, AND DETECTION KIT |
| 02/24/2011 | WO2011021142A1 Detection of different target components by cluster formation |
| 02/24/2011 | WO2011021041A2 Survival prognostic assay |
| 02/24/2011 | WO2011020925A1 Anti-cmet antibody and its use for the detection and the diagnosis of cancer |
| 02/24/2011 | WO2011020914A1 Simplified magazining of integrated systems |
| 02/24/2011 | WO2011020874A1 Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy |
| 02/24/2011 | WO2011020865A1 Apolipoprotein l- i variants and their use |
| 02/24/2011 | WO2011020839A1 A method of predicting response to thalidomide in multiple myeloma patients |
| 02/24/2011 | WO2011020724A1 Test system for visual analysis |
| 02/24/2011 | WO2011020611A1 Impedance determination of intracellular calcium activity |
| 02/24/2011 | WO2011020434A1 Antibody binding to the protein of the bacteriophage of mycobacterium tuberculosis, and the preparation method and use thereof |
| 02/24/2011 | WO2011020187A1 Methods and systems for the quantitative chemical speciation of heavy metals and other toxic pollutants |
| 02/24/2011 | WO2011020183A1 Screening of protein candidates |
| 02/24/2011 | WO2010144157A9 Molecular imprinted nanosensors |
| 02/24/2011 | WO2010141596A3 Chemical proteomic assay for optimizing drug binding to target proteins |
| 02/24/2011 | WO2010140827A9 Automatic detection kit for hla alleles by real-time polymerase chain reaction |
| 02/24/2011 | WO2010135417A3 Multilayer colorimetric sensor arrays |
| 02/24/2011 | WO2010135413A3 Multilayer colorimetric sensors |
| 02/24/2011 | WO2010135364A3 Multi-directional microfluidic devices and methods |
| 02/24/2011 | WO2010123883A3 Photoacoustic detection of analytes in solid tissue and detection system |
| 02/24/2011 | WO2010123216A3 Method for using cfh or apoh as a biochemical marker for diagnosis of acute myeloid leukemia |
| 02/24/2011 | WO2010121176A3 Microtensiometer |
| 02/24/2011 | WO2010120942A3 Histone modification patterns for clinical diagnosis and prognosis of cancer |
| 02/24/2011 | WO2010115077A9 Biomarker panels for barrett's esophagus and esophageal adenocarcinoma |
| 02/24/2011 | WO2010107946A3 Use of thermostable endonucleases for generating reporter molecules |
| 02/24/2011 | WO2010105235A3 Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy |
| 02/24/2011 | WO2010099108A3 Multiplexing derivatized anayltes using mass spectroscopy |
| 02/24/2011 | WO2010093223A3 Target substance detection method using aptamer |
| 02/24/2011 | WO2010091235A3 Compositions, kits, and methods for determining plasmin activity |
| 02/24/2011 | WO2010088522A3 Novel lowered affinity antibodies and uses therefor |
| 02/24/2011 | WO2010087912A8 Hydrogels crosslinked with gold nanoparticles |
| 02/24/2011 | WO2010043393A8 Use of biglycan in the assessment of heart failure |
| 02/24/2011 | WO2010004436A8 Enhanced immunoassay sensor |
| 02/24/2011 | WO2009108802A8 Method for patient genotyping |
| 02/24/2011 | WO2008009585A3 Portable measuring system having an optimized assembly space |
| 02/24/2011 | US20110047643 Dry bean line 08550815 |
| 02/24/2011 | US20110047634 Methods and compositions for the diagnosis and treatment of acute lymphoblastic leukemia |
| 02/24/2011 | US20110047633 Control of Exocrine Pancreatic Function Using Bone Morphogenetic Proteins |
| 02/24/2011 | US20110047632 Fibrinogen immune complexes to diagnose and guide therapy in rheumatoid arthritis |
| 02/24/2011 | US20110047631 Heat shock protein deficiencies as model systems for brain pathology and cancer |
| 02/24/2011 | US20110046895 Method and Device for Utilizing Analyte Levels to Assist in the Treatment of Diabetes |
| 02/24/2011 | US20110046894 Method for discriminating between malignant and benign tissue lesions |
| 02/24/2011 | US20110046893 Method for normalizing the results of an in-vitro analytical method |
| 02/24/2011 | US20110046892 Method and Device for Utilizing Analyte Levels to Assist in the Treatment of Diabetes |
| 02/24/2011 | US20110046888 Method of diagnosing tumor disorders in humans |
| 02/24/2011 | US20110046887 Method for assessing pathway product levels |
| 02/24/2011 | US20110046469 Glucose Measuring Device for Use In Personal Area Network |
| 02/24/2011 | US20110046364 Method of labeling sugar chain |
| 02/24/2011 | US20110046351 Mutant proteins and methods for selecting them |
| 02/24/2011 | US20110046207 C5a binding nucleic acids |
| 02/24/2011 | US20110046205 Method for dissolving charged nucleic acid in an organic liquid |
| 02/24/2011 | US20110046204 Human Zip1, Zinc and Citrate for Prostate Cancer Screening |
| 02/24/2011 | US20110046187 Assessing congestive heart risk in patients treated or potentially to be treated with a peroxisome-proliferator-activator-receptor-gamma agonist or a thiazolidinedione |
| 02/24/2011 | US20110046094 Methods and compositions for identifying and treating lupus |
| 02/24/2011 | US20110046092 Small molecules for neuronal differentiation of embryonic stem cells |
| 02/24/2011 | US20110046073 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling |
| 02/24/2011 | US20110046068 Compound, Use and Method |
| 02/24/2011 | US20110046051 Method and Device for Utilizing Analyte Levels to Assist in the Treatment of Diabetes |
| 02/24/2011 | US20110046029 Combinations of Phosphorus-Containing Compounds For Use As Anti-Wear Additives In Lubricant Compositions |
| 02/24/2011 | US20110046008 Screening assays and methods |
| 02/24/2011 | US20110046007 Probe, probe set, probe carrier, and testing method |
| 02/24/2011 | US20110046005 Method and nucleic acids for the analysis of colon cell proliferative disorders |
| 02/24/2011 | US20110046004 Magnetic-nanoparticle conjugates and methods of use |
| 02/24/2011 | US20110046002 Seven Gene Breast Cancer Predictor |
| 02/24/2011 | US20110046000 Methods to increase the photostability of dyes |
| 02/24/2011 | US20110045998 Candidate genes and blood biomarkers for bipolar mood disorder, alcoholism and stress disorder |